TMC Life Sciences Berhad (TMCLS) is one of the fastest growing healthcare groups in Malaysia. It has been listed on the Main Market of Bursa Malaysia Securities Berhad since 2005. The Group aims to be the “Integrated Healthcare System of Choice in Southeast Asia” delivering quality, value-based care to its patients and customers. TMCLS has embarked on a major expansion plan, with significant additional capacity and capabilities coming on stream from 2021 onwards.
The plan includes the expansion of its flagship hospital, Thomson Hospital Kota Damansara, increasing its capacity to 559 beds with additional specialist centres, operating theatres, Oncology & Nuclear Medicine centre, Eye Health centre and multi-storey carpark. A new integrated medical hub – Thomson Iskandar – is being developed in the proposed Vantage Bay Healthcare City in bustling Johor Bahru. Located just off the Causeway linking Johor and Singapore, Thomson Iskandar will house a 500-bed tertiary hospital, specialist medical suites and related health and wellness facilities.